Literature DB >> 3889712

Sharing increasing costs on declining income: the visible dilemma of the invisible aged.

B B Torrey.   

Abstract

The federal government considers all persons aged 65 and over a single beneficiary group, and data collectors consider them a single cohort. As a result, the very old (80 years and over) are virtually invisible; little is known about their specific income benefits and economic resources. Costs for the very old--a more economically diverse group than the nonaged--are likely to grow disproportionately. Recent proposals to share costs will affect the distribution of income and assets among the aged and between generations.

Entities:  

Mesh:

Year:  1985        PMID: 3889712

Source DB:  PubMed          Journal:  Milbank Mem Fund Q Health Soc        ISSN: 0160-1997


  6 in total

1.  Modernization and the status of the frail elderly: Perspectives on continuity and change.

Authors:  B J Logue
Journal:  J Cross Cult Gerontol       Date:  1990-10

2.  Economic stress among adult-child caregivers of the oldest old in China: the importance of contextual factors.

Authors:  Jinyu Liu; Man Guo; Mercedes Bern-Klug
Journal:  J Cross Cult Gerontol       Date:  2013-12

3.  A birth cohort analysis of dental contact among elderly Americans.

Authors:  F D Wolinsky; C L Arnold
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

4.  Towards Deeper Research and Better Policy for Healthy Aging --Using the Unique Data of Chinese Longitudinal Healthy Longevity Survey.

Authors:  Yi Zeng
Journal:  China Economic J       Date:  2012

5.  Impact of growing numbers of the very old on Medicaid expenditures for nursing homes: a multi-state, population-based analysis.

Authors:  W A Ray; C F Federspiel; D K Baugh; S Dodds
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

6.  Surgical procedures among those greater than or equal to 90 years of age. A population-based study in Olmsted County, Minnesota, 1975-1985.

Authors:  M A Warner; M P Hosking; C M Lobdell; K P Offord; L J Melton
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.